Bassali J, Gould IG, Kaye JA, Mladsi D, & Mehta J. (2020). US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma. Dove Medical Press.
Chicago Style (17th ed.) CitationBassali J, Gould IG, Kaye JA, Mladsi D, and Mehta J. US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma. Dove Medical Press, 2020.
MLA (9th ed.) CitationBassali J, et al. US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.